| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 83,182 | 78,303 | 71,126 | 78,693 | | Cost of Revenue | 57,112 | 52,808 | 49,689 | 53,378 | | | Gross Profit | 26,070 | 25,495 | 21,437 | 25,315 | | | Operating Expenses | | Research Development | 2,251 | 2,050 | 2,110 | 1,858 | | Selling General and Administrative | 17,175 | 17,758 | 17,791 | 15,646 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,644 | 5,687 | 1,536 | 7,811 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 135 | 309 | (229) | 916 | | Earnings Before Interest And Taxes | 6,779 | 5,996 | 1,307 | 8,727 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 6,779 | 5,996 | 1,307 | 8,727 | | Income Tax Expense | 2,556 | 2,180 | 511 | 2,894 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,223 | 3,816 | 796 | 5,833 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,223 | 3,816 | 796 | 5,833 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,223 | $3,816 | $796 | $5,833 |
|
0.51% Nasdaq 
Income Statement
